Screening for hemochromatosis in asymptomatic subjects with or without a family history

被引:144
|
作者
Powell, LW [1 ]
Dixon, JL
Ramm, GA
Purdie, DM
Lincoln, DJ
Anderson, GJ
Subramaniam, VN
Hewett, DG
Searle, JW
Fletcher, LM
Crawford, DH
Rodgers, H
Allen, KJ
Cavanaugh, JA
Bassett, ML
机构
[1] Royal Brisbane & Womens Hosp, Ctr Advancement Clin Res, Queensland Inst Med Res, Dept Gastroenterol & Hepatol, Brisbane, Qld 4029, Australia
[2] Royal Brisbane & Womens Hosp, Ctr Advancement Clin Res, Queensland Inst Med Res, Dept Anat Pathol, Brisbane, Qld 4029, Australia
[3] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia
[4] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[5] Canberra Hosp, Dept Gastroenterol, Canberra, ACT, Australia
[6] Canberra Hosp, Dept Med Genet, Canberra, ACT, Australia
[7] Australian Natl Univ, Canberra, ACT, Australia
关键词
D O I
10.1001/archinte.166.3.294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hemochromatosis in white subjects is mostly due to homozygosity for the common C282Y substitution in HFE. Although clinical symptoms are preventable by early detection of the genetic predisposition and prophylactic treatment, population screening is not currently advocated because of the discrepancy between the common mutation prevalence and apparently lower frequency of clinical disease. This study compared screening for hemochromatosis in subjects with or without a family history. Methods: We assessed disease expression by clinical evaluation and liver biopsy in 672 essentially asymptomatic C282Y homozygous subjects identified by either family screening or health checks. We also observed a subgroup of untreated homozygotes with normal serum ferritin levels for up to 24 years. Results: Prevalence of hepatic iron overload and fibrosis were comparable between the 2 groups. Disease-related conditions were more common in male subjects identified by health checks, but they were older. Hepatic iron overload (grades 2-4) was present in 56% and 34.5% of male and female subjects, respectively; hepatic fibrosis (stages 2-4) in 18.4% and 5.4%; and cirrhosis in 5.6% and 1.9%. Hepatic fibrosis and cirrhosis correlated significantly with the hepatic iron concentration, and except in cases of cirrhosis, there was a 7.5-fold reduction in the mean fibrosis score after phlebotomy. All subjects with cirrhosis were asymptomatic. Conclusions: Screening for hemochromatosis in apparently healthy subjects homozygous for the C282Y mutation with or without a family history reveals comparable levels of hepatic iron overload and disease. Significant hepatic fibrosis is frequently found in asymptomatic subjects with hemochromatosis and, except when cirrhosis is present, is reversed by iron removal.
引用
收藏
页码:294 / 301
页数:8
相关论文
共 50 条
  • [41] Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension
    Herlitz, H
    Jungersten, LU
    Wikstrand, J
    Widgren, BR
    KIDNEY INTERNATIONAL, 1999, 56 (05) : 1838 - 1845
  • [42] SCREENING FOR HEMOCHROMATOSIS
    MCCURDY, P
    AMERICAN FAMILY PHYSICIAN, 1981, 24 (05) : 53 - &
  • [43] HEMOCHROMATOSIS SCREENING
    TANNER, AR
    WRIGHT, R
    LANCET, 1988, 2 (8605): : 286 - 286
  • [44] Screening for hemochromatosis
    McCullen, MA
    Crawford, DHG
    Hickman, PE
    CLINICA CHIMICA ACTA, 2002, 315 (1-2) : 169 - 186
  • [45] SCREENING FOR HEMOCHROMATOSIS
    BASSETT, ML
    HALLIDAY, JW
    BRYANT, S
    DENT, O
    POWELL, LW
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 526 : 274 - 289
  • [46] SCREENING FOR HEMOCHROMATOSIS
    KUSHNER, JP
    GASTROENTEROLOGY, 1995, 109 (01) : 315 - 316
  • [47] Screening for hemochromatosis
    Bacon, BR
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (03) : 269 - 270
  • [48] SCREENING FOR HEMOCHROMATOSIS
    MAGUIRE, GA
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (27): : 2037 - 2037
  • [49] Screening for hemochromatosis
    Asberg, Arne
    Thorstensen, Ketil
    Irgens, Wenche
    Hveem, Kristian
    BLOOD, 2008, 111 (07) : 3896 - 3896
  • [50] SCREENING FOR HEMOCHROMATOSIS
    LEDERLE, FA
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1989, 4 (01) : 61 - 63